SciMatic
Journals
Thesis Rep
Docs
Products
SciMatic.net
Journament
Journal Manager
Subjects
Thesis
ImProofer
Research Groups
Letter Pad
Conferences
Services
About
SciMatic
Blog
Team
Earn With Us
Join Us
Contact Us
EN
English
Türkçe
Español
Português
Pусский
Filipino
Tiếng Việt
हिन्दी
العربية
বাংলা
Deutsch
中文
Login
Keyword Connections
pd-1
Journals
6
1
PloS one
2
International journal of biological macromolecules
3
Frontiers in immunology
4
European journal of cancer (Oxford, England : 1990)
5
Virology
6
journal of autoimmunity
Research Groups
0
No Research Group Connected
Bibliographies
18
1
Chronic Immune Activation in Systemic Lupus Erythematosus and the Autoimmune PTPN22 Trp Risk Allele Drive the Expansion of FOXP3 Regulatory T Cells and PD-1 Expression.
2
Analysis of the PD-1/PD-L1 axis in human autoimmune thyroid disease: Insights into pathogenesis and clues to immunotherapy associated thyroid autoimmunity.
3
Combinatorial treatment increases IKAP levels in human cells generated from Familial Dysautonomia patients.
4
Antimicrobial, anticancer and antioxidant activities of nano-heart of Phoenix dactylifera tree extract loaded chitosan nanoparticles: In vitro and in vivo study.
5
Immune-related pneumonitis with nivolumab and ipilimumab during the coronavirus disease 2019 (COVID-19) pandemic.
6
the role of micrornas in aβ deposition and tau phosphorylation in alzheimer’s disease
7
pd-1/pd-l1 blockade: have we found the key to unleash the antitumor immune response?
8
cancer immunotherapies targeting the pd-1 signaling pathway
9
albumin/globulin ratio is negatively correlated with pd-1 and cd25 mrna levels in breast cancer patients
10
reversing egfr mediated immunoescape by targeted monoclonal antibody therapy
11
the efficacy and safety of nivolumab in previously treated advanced non-small-cell lung cancer: a meta-analysis of prospective clinical trials
12
prognostic significance of pretreatment albumin/globulin ratio in patients with hepatocellular carcinoma
13
advances of pd-1/pd-l1 inhibitors in tumor immunotherapy
14
Tackling Cancer Resistance by Immunotherapy: Updated Clinical Impact and Safety of PD-1/PD-L1 Inhibitors
15
PD-1/PD-L1 Blockade Therapy for Tumors with Downregulated MHC Class I Expression
16
Targeting Immune Cell Checkpoints during Sepsis
17
Oncolytic Reovirus and Immune Checkpoint Inhibition as a Novel Immunotherapeutic Strategy for Breast Cancer
18
Prognostic value of PD-1, PD-L1 and PD-L2 deserves attention in head and neck cancer.
×
SciMatic on Your Phone
Track your articles, view certificates, and stay updated — anywhere, anytime.
Google Play